ATE10838T1 - 4-substituierte 2-oxoazetidin-verbindungen, verfahren zu deren herstellung und ihre verwendung zur antibiotika-herstellung. - Google Patents

4-substituierte 2-oxoazetidin-verbindungen, verfahren zu deren herstellung und ihre verwendung zur antibiotika-herstellung.

Info

Publication number
ATE10838T1
ATE10838T1 AT81101322T AT81101322T ATE10838T1 AT E10838 T1 ATE10838 T1 AT E10838T1 AT 81101322 T AT81101322 T AT 81101322T AT 81101322 T AT81101322 T AT 81101322T AT E10838 T1 ATE10838 T1 AT E10838T1
Authority
AT
Austria
Prior art keywords
processes
antibiotics
substituted
manufacture
production
Prior art date
Application number
AT81101322T
Other languages
English (en)
Inventor
Masashi Hashimoto
Matsuhiko Aratani
Kozo Sawada
Original Assignee
Fujisawa Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co., Ltd. filed Critical Fujisawa Pharmaceutical Co., Ltd.
Application granted granted Critical
Publication of ATE10838T1 publication Critical patent/ATE10838T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02Preparation
    • C07D477/04Preparation by forming the ring or condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
AT81101322T 1980-02-28 1981-02-24 4-substituierte 2-oxoazetidin-verbindungen, verfahren zu deren herstellung und ihre verwendung zur antibiotika-herstellung. ATE10838T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8006842 1980-02-28
EP81101322A EP0035689B1 (de) 1980-02-28 1981-02-24 4-Substituierte 2-Oxoazetidin-Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung zur Antibiotika-Herstellung

Publications (1)

Publication Number Publication Date
ATE10838T1 true ATE10838T1 (de) 1985-01-15

Family

ID=10511761

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81101322T ATE10838T1 (de) 1980-02-28 1981-02-24 4-substituierte 2-oxoazetidin-verbindungen, verfahren zu deren herstellung und ihre verwendung zur antibiotika-herstellung.

Country Status (5)

Country Link
US (2) US4383945A (de)
EP (1) EP0035689B1 (de)
JP (1) JPS56131565A (de)
AT (1) ATE10838T1 (de)
DE (1) DE3167774D1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52147B1 (en) * 1980-03-27 1987-07-08 Merck & Co Inc 4-(3-carboxy-2-oxopropyl)-azetidin-2-ones and process for their preparation
JPS58167564A (ja) * 1982-03-29 1983-10-03 Nippon Kayaku Co Ltd 4−(3−アルコキシカルボニル−2−オキソプロビル)−2−アゼチジノン誘導体の製造法
JPS58192866A (ja) * 1982-04-30 1983-11-10 Kanegafuchi Chem Ind Co Ltd 2―アゼチジノン誘導体
US4771135A (en) * 1984-05-22 1988-09-13 Eli Lilly And Company Process for carbon-carbon bond formation at the C-4 position of 3-acylaminoazetidinones and products and starting materials therefor
CA1249279A (en) * 1984-05-22 1989-01-24 Larry C. Blaszczak Process for carbon-carbon bond formation at the c-4 position of 3-acylaminoazetidinones
US4918185A (en) * 1984-05-22 1990-04-17 Eli Lilly And Company Process for carbon-carbon bond formation at the C-4 position of 3-acylaminoazetidinones and products and starting materials therefor
DE3509769A1 (de) * 1985-03-19 1986-09-25 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von carbapenemzwischenprodukten
DE3678275D1 (de) * 1986-01-08 1991-04-25 Merck & Co Inc Verfahren zur herstellung chiraler 1-beta-methylcarbapenem-zwischenverbindungen.
US4816578A (en) * 1986-06-24 1989-03-28 Merck & Co., Inc. Process for the stereocontrolled silyloxyethylation of azetidinones
US4960879A (en) * 1988-03-23 1990-10-02 Shionogi & Co., Ltd. Process for carbapenem intermediates
US4876365A (en) * 1988-12-05 1989-10-24 Schering Corporation Intermediate compounds for preparing penems and carbapenems
US5239069A (en) * 1990-05-14 1993-08-24 Eli Lilly And Company Amino protecting group
US7772392B2 (en) * 2005-05-06 2010-08-10 Allergan, Inc. Therapeutic substituted β-lactams
WO2008144623A1 (en) * 2007-05-23 2008-11-27 Allergan, Inc. Cyclic lactams for the treatment of glaucoma or elevated intraocular pressure
CN111675641B (zh) * 2020-06-04 2023-09-08 宁夏农林科学院农业资源与环境研究所(宁夏土壤与植物营养重点实验室) 单环β-内酰胺类化合物、单环内酰胺类化合物盐及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK523676A (da) * 1975-11-21 1977-05-22 Merck & Co Inc Fremgangsmade til fremstilling af n-alkylerede derivater af thienamycin
US4115383A (en) * 1976-02-23 1978-09-19 Eli Lilly And Company Alkoxycarbonyl-ethylthio-azetidinones and process for their preparation
US4187221A (en) * 1976-12-31 1980-02-05 Connlab Holdings Limited Process for preparing azetidinones
GB1584762A (en) * 1977-04-01 1981-02-18 Beecham Group Ltd Azabicycloheptenes
AU4061378A (en) * 1977-10-19 1980-04-17 Merck & Co., Inc. 1-azabicyclo (3.2.0) hept-2-enes
EP0005507A1 (de) * 1978-05-18 1979-11-28 Ciba-Geigy Ag Fragmentierungsverfahren von 3-(2-Hydroxyimino-acetylamino)-2-oxo-azetidin-Verbindungen und die erhaltenen Verbindungen
US4174316A (en) * 1978-08-14 1979-11-13 Merck & Co., Inc. 4-Iodomethylazetidin-2-one
US4273709A (en) * 1979-07-23 1981-06-16 Merck & Co., Inc. Process for the preparation of thienamycin and intermediates
JPS57116072A (en) * 1981-01-12 1982-07-19 Takeda Chem Ind Ltd Beta-lactam compound and its preparation

Also Published As

Publication number Publication date
US4539152A (en) 1985-09-03
US4383945A (en) 1983-05-17
DE3167774D1 (en) 1985-01-31
EP0035689A1 (de) 1981-09-16
JPS56131565A (en) 1981-10-15
JPH023781B2 (de) 1990-01-24
EP0035689B1 (de) 1984-12-19

Similar Documents

Publication Publication Date Title
ATE10838T1 (de) 4-substituierte 2-oxoazetidin-verbindungen, verfahren zu deren herstellung und ihre verwendung zur antibiotika-herstellung.
ATE206422T1 (de) Verfahren zur herstellung von aryl-piperazinyl- heterocyclischen derivaten
ATE113281T1 (de) Pyrazol-derivate, verfahren zu deren herstellung und anwendung.
ES518227A0 (es) Procedimiento para preparar nuevos compuestos de cefem.
NO844139L (no) Nye 1-substituerte-5-hydroksymetyl-2-merkapto-imidazol-derivater og fremgangsmaate for fremstilling derav
ES543153A0 (es) Metodo de preparar derivados de b-carbolin-3-oxadiazolilo
ATE31414T1 (de) 8-substituierte pyrrolizidin-derivate und deren verwendung.
ATE2324T1 (de) Triazolyl-alken-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
PT73841A (en) Process for preparing novel guanidine derivatives
DE3866148D1 (de) Chinolincarbonsaeure-derivate, diese enthaltende zusammensetzung, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von medikamenten.
ATE31928T1 (de) Acylamino-4-aza-1-adamantane, verfahren zu ihrer herstellung und ihre anwendung in der therapeutik.
ES532098A0 (es) Un procedimiento para preparar derivados sustituidos en posicion 1 de azetidin-3-ol
ES2068663T3 (es) Procedimiento para la preparacion de compuestos de piridina sustituidos con halogenosulfonilo.
ATE157971T1 (de) Verfahren zur herstellung von aminotriazin- derivaten
FR2485539B1 (de)
ES8307766A1 (es) Procedimiento para la preparacion de derivados de azolil-penteno.
SE8005127L (sv) Sett att framstella 15-hydroxiimino-e-homoeburnanderivat
ATE10370T1 (de) Benzothiazinderivate, verfahren zu ihrer herstellung und ihre verwendung.
ES532507A0 (es) Un metodo de preparar espiro (indolo (1, 7-ab) (1, 5)-benzodiazepin-2, 4'-piperidinas)
ATE17851T1 (de) Imidazolylkarbonsaeure, deren derivate und herstellung.
ATE29253T1 (de) Verfahren zur herstellung von 4-chinolinonen.
DK566181A (da) Fremgangsmaade til fremstilling af n-pyrrolylpyridazinaminderivater
ES8302712A1 (es) Un nuevo procedimiento de preparacion de imidazobenzodiazepinas.
DK452684D0 (da) Fremgangsmaade til fremstilling af quinolin-4-oner
ATE455T1 (de) Verfahren zur herstellung von carbazolen und ein zwischenprodukt hierfuer.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee